IS8515A - Ný M3 múskarínasetýlkólínviðtakamótlyf - Google Patents
Ný M3 múskarínasetýlkólínviðtakamótlyfInfo
- Publication number
- IS8515A IS8515A IS8515A IS8515A IS8515A IS 8515 A IS8515 A IS 8515A IS 8515 A IS8515 A IS 8515A IS 8515 A IS8515 A IS 8515A IS 8515 A IS8515 A IS 8515A
- Authority
- IS
- Iceland
- Prior art keywords
- new
- receptor antagonists
- acetylcholine receptor
- muscarinic acetylcholine
- muscarinic
- Prior art date
Links
- 229940121683 Acetylcholine receptor antagonist Drugs 0.000 title 1
- 102000014415 Muscarinic acetylcholine receptor Human genes 0.000 title 1
- 108050003473 Muscarinic acetylcholine receptor Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Pulmonology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Hydrogenated Pyridines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US52682403P | 2003-12-03 | 2003-12-03 | |
| PCT/US2004/040667 WO2005055940A2 (en) | 2003-12-03 | 2004-12-03 | Novel m3 muscarinic acetylcholine receptor antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IS8515A true IS8515A (is) | 2006-06-19 |
Family
ID=34676665
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IS8515A IS8515A (is) | 2003-12-03 | 2006-06-19 | Ný M3 múskarínasetýlkólínviðtakamótlyf |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20070179184A1 (is) |
| EP (1) | EP1708702A2 (is) |
| JP (1) | JP2007513181A (is) |
| KR (1) | KR20060123415A (is) |
| AR (1) | AR046784A1 (is) |
| AU (1) | AU2004296207A1 (is) |
| BR (1) | BRPI0417215A (is) |
| CA (1) | CA2549272A1 (is) |
| IL (1) | IL175995A0 (is) |
| IS (1) | IS8515A (is) |
| MA (1) | MA28217A1 (is) |
| MX (1) | MXPA06006372A (is) |
| NO (1) | NO20062992L (is) |
| PE (1) | PE20050897A1 (is) |
| UY (1) | UY28645A1 (is) |
| WO (1) | WO2005055940A2 (is) |
| ZA (1) | ZA200604395B (is) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200519108A (en) * | 2003-07-17 | 2005-06-16 | Glaxo Group Ltd | Muscarinic acetylcholine receptor antagonists |
| AR046114A1 (es) * | 2003-10-17 | 2005-11-23 | Glaxo Group Ltd | Compuesto de 8- azoniabiciclo (3.2.1) octano, composicion farmaceutica para el tratamiento de enfermedades mediadas por receptores de acetilcolina muscarinicos y uso del compuesto para preparar dicha composicion |
| PE20050489A1 (es) * | 2003-11-04 | 2005-09-02 | Glaxo Group Ltd | Antagonistas de receptores de acetilcolina muscarinicos |
| US20090253908A1 (en) * | 2004-03-11 | 2009-10-08 | Glaxo Group Limited | Novel m3 muscarinic acetylchoine receptor antagonists |
| JP2007529511A (ja) * | 2004-03-17 | 2007-10-25 | グラクソ グループ リミテッド | Ｍ３ムスカリン性アセチルコリン受容体アンタゴニスト |
| WO2005095407A1 (en) * | 2004-03-17 | 2005-10-13 | Glaxo Group Limited | M3 muscarinic acetylcholine receptor antagonists |
| TWI363759B (en) | 2004-04-27 | 2012-05-11 | Glaxo Group Ltd | Muscarinic acetylcholine receptor antagonists |
| US7598267B2 (en) * | 2004-05-13 | 2009-10-06 | Glaxo Group Limited | Muscarinic acetylcholine receptor antagonists |
| US7868037B2 (en) | 2004-07-14 | 2011-01-11 | Ptc Therapeutics, Inc. | Methods for treating hepatitis C |
| US7772271B2 (en) | 2004-07-14 | 2010-08-10 | Ptc Therapeutics, Inc. | Methods for treating hepatitis C |
| US7781478B2 (en) | 2004-07-14 | 2010-08-24 | Ptc Therapeutics, Inc. | Methods for treating hepatitis C |
| EP1771169A1 (en) | 2004-07-14 | 2007-04-11 | PTC Therapeutics, Inc. | Methods for treating hepatitis c |
| AU2005275182A1 (en) | 2004-07-22 | 2006-02-23 | Ptc Therapeutics, Inc. | Thienopyridines for treating Hepatitis C |
| JP2008509910A (ja) * | 2004-08-10 | 2008-04-03 | インサイト・コーポレイション | アミド化合物およびその医薬としての使用 |
| WO2006055553A2 (en) * | 2004-11-15 | 2006-05-26 | Glaxo Group Limited | Novel m3 muscarinic acetylcholine receptor antagonists |
| EP1937267A4 (en) * | 2005-08-02 | 2009-08-26 | Glaxo Group Ltd | M3-MUSCARIN ACETYLCHOLIN RECEPTOR ANTAGONISTS |
| WO2007022351A2 (en) * | 2005-08-18 | 2007-02-22 | Glaxo Group Limited | Muscarinic acetylcholine receptor antagonists |
| PE20091552A1 (es) | 2008-02-06 | 2009-10-25 | Glaxo Group Ltd | Farmacoforos duales - antagonistas muscarinicos de pde4 |
| CL2009000249A1 (es) | 2008-02-06 | 2009-09-11 | Glaxo Group Ltd | Compuestos derivados de pirazolo[3,4-b] piridin-butanodiamida; composicion farmaceutica; y su uso en el tratamiento del asma, enfermedad pulmonar obstructiva cronica, rinitis, dermatitis atopica, psoriasis. |
| TW200946526A (en) | 2008-02-06 | 2009-11-16 | Glaxo Group Ltd | Dual pharmacophores-PDE4-muscarinic antagonistics |
| WO2010094643A1 (en) | 2009-02-17 | 2010-08-26 | Glaxo Group Limited | Quinoline derivatives and their uses for rhinitis and urticaria |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5232978A (en) * | 1988-12-23 | 1993-08-03 | Merck Patent Gesellschaft Mit Beschrankter Haftung | 1-(2-arylethyl)-pyrrolidines |
| WO1999067221A1 (en) * | 1998-06-22 | 1999-12-29 | Elan Pharmaceuticals, Inc. | Compounds for inhibiting beta-amyloid peptide release and/or its synthesis |
| US6420364B1 (en) * | 1999-09-13 | 2002-07-16 | Boehringer Ingelheim Pharmaceuticals, Inc. | Compound useful as reversible inhibitors of cysteine proteases |
-
2004
- 2004-12-01 UY UY28645A patent/UY28645A1/es unknown
- 2004-12-01 AR ARP040104479A patent/AR046784A1/es unknown
- 2004-12-01 PE PE2004001185A patent/PE20050897A1/es not_active Application Discontinuation
- 2004-12-03 WO PCT/US2004/040667 patent/WO2005055940A2/en active Application Filing
- 2004-12-03 CA CA002549272A patent/CA2549272A1/en not_active Abandoned
- 2004-12-03 EP EP04813055A patent/EP1708702A2/en not_active Withdrawn
- 2004-12-03 KR KR1020067013265A patent/KR20060123415A/ko not_active Withdrawn
- 2004-12-03 JP JP2006542825A patent/JP2007513181A/ja active Pending
- 2004-12-03 BR BRPI0417215-9A patent/BRPI0417215A/pt not_active Application Discontinuation
- 2004-12-03 AU AU2004296207A patent/AU2004296207A1/en not_active Abandoned
- 2004-12-03 US US10/581,230 patent/US20070179184A1/en not_active Abandoned
- 2004-12-03 MX MXPA06006372A patent/MXPA06006372A/es unknown
-
2006
- 2006-05-29 IL IL175995A patent/IL175995A0/en unknown
- 2006-05-30 ZA ZA200604395A patent/ZA200604395B/en unknown
- 2006-06-02 MA MA29068A patent/MA28217A1/fr unknown
- 2006-06-19 IS IS8515A patent/IS8515A/is unknown
- 2006-06-27 NO NO20062992A patent/NO20062992L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0417215A (pt) | 2007-02-21 |
| AR046784A1 (es) | 2005-12-21 |
| EP1708702A2 (en) | 2006-10-11 |
| WO2005055940A3 (en) | 2005-09-15 |
| WO2005055940A2 (en) | 2005-06-23 |
| PE20050897A1 (es) | 2005-11-06 |
| IL175995A0 (en) | 2006-10-05 |
| CA2549272A1 (en) | 2005-06-23 |
| US20070179184A1 (en) | 2007-08-02 |
| AU2004296207A1 (en) | 2005-06-23 |
| ZA200604395B (en) | 2007-10-31 |
| KR20060123415A (ko) | 2006-12-01 |
| JP2007513181A (ja) | 2007-05-24 |
| MXPA06006372A (es) | 2006-08-23 |
| NO20062992L (no) | 2006-06-27 |
| MA28217A1 (fr) | 2006-10-02 |
| UY28645A1 (es) | 2005-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IS8522A (is) | Ný M3 múskarínasetýlkólínviðtakamótlyf | |
| IS8515A (is) | Ný M3 múskarínasetýlkólínviðtakamótlyf | |
| CY2014043I1 (el) | Ανταγωνιστες μουσκαρινικου υποδοχεα ακετυλοχολινης | |
| DK1682142T3 (da) | M3-muscarin-acetylcholin-receptor-antagonister | |
| ATE494285T1 (de) | Muscarinische acetylcholin-rezeptor-antagonisten | |
| ZA200602783B (en) | Muscarinic acetylcholine receptor antagonists | |
| IL176775A0 (en) | Muscarinic acetylcholine receptor antagonists | |
| EP1725240A4 (en) | ANTAGONISTS OF THE ACETYLCHOLINE MUSCARINIC RECEPTOR | |
| EP1937230A4 (en) | M3-MUSCARIN ACETYLCHOLIN RECEPTOR ANTAGONISTS | |
| EP1937267A4 (en) | M3-MUSCARIN ACETYLCHOLIN RECEPTOR ANTAGONISTS | |
| EP1725236A4 (en) | NEW M3 MUSCARIN ACETYLCHOLINE RECEPTOR ANTAGONISTS | |
| EP1648460A4 (en) | ANTAGONISTS OF MUSCARIN ACETYLCHOLIN RECEPTOR | |
| EP1957075A4 (en) | NOVEL ANTAGONISTS OF ACETYLCHOLINE M3 TYPE MUSCARINIC RECEPTORS | |
| IL172912A0 (en) | Muscarinic acetylcholine receptor antagonists | |
| IL172911A0 (en) | Muscarinic acetylcholine receptor antagonists | |
| EP1827439A4 (en) | NEW M3 MUSCARIN ACETYLCHOLINE RECEPTOR ANTAGONISTS | |
| EP1725241A4 (en) | ANTAGONISTS OF THE ACETYLCHOLINE MUSCARINIC M3 RECEPTOR | |
| EP1824483A4 (en) | ANTAGONISTS OF ACETYLCHOLINE MUSCARINIC RECEPTORS | |
| EP1749012A4 (en) | ANTAGONISTS OF MUSCARIN ACETYLCHOLIN RECEPTOR | |
| EP1725564A4 (en) | ANTAGONISTS OF THE M3 MUSCARIN ACETYL CHOLIN RECEPTOR | |
| EP1765339A4 (en) | ANTAGONISTS OF MUSCARIN ACETYLCHOLIN RECEPTOR | |
| EP1781104A4 (en) | ANTAGONISTS OF THE ACETYLCHOLINE MUSCARINIC RECEPTOR | |
| EP1781103A4 (en) | ANTAGONISTS OF THE ACETYLCHOLINE MUSCARINIC RECEPTOR | |
| EP1751089A4 (en) | NEW M3 MUSCARIN ACETYLCHOLINE RECEPTOR ANTAGONISTS | |
| HK1097741A (en) | Novel m3 muscarinic acetylcholine receptor antagonists |